Axel Hauschild Selected Research

Axel Hauschild Research Topics

Disease

151	Melanoma (Melanoma, Malignant) 11/2022 - 02/2003
55	Neoplasms (Cancer) 01/2022 - 01/2005
25	Neoplasm Metastasis (Metastasis) 10/2021 - 02/2003
13	Basal Cell Carcinoma (Rodent Ulcer) 01/2021 - 11/2002
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 06/2011
9	Disease Progression 01/2021 - 08/2006
8	Exanthema (Rash) 11/2021 - 03/2011
6	Brain Neoplasms (Brain Tumor) 01/2021 - 02/2008
6	Fatigue 10/2018 - 07/2008
5	Skin Neoplasms (Skin Cancer) 10/2021 - 10/2005
4	Fever (Fevers) 11/2021 - 07/2012
4	Lymphatic Metastasis 01/2021 - 08/2003
4	Diarrhea 10/2018 - 06/2009
4	Body Weight (Weight, Body) 01/2018 - 06/2011
4	Neutropenia 07/2014 - 07/2012
3	Merkel Cell Carcinoma 07/2018 - 01/2017
3	Keratoacanthoma 01/2015 - 06/2011
3	Alopecia (Baldness) 07/2014 - 10/2008
3	Arthralgia (Joint Pain) 07/2012 - 10/2008
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2005
2	HIV Infections (HIV Infection) 01/2022 - 01/2005
2	Pain (Aches) 01/2021 - 10/2015
2	Basal Cell Nevus Syndrome (Gorlin Syndrome) 01/2020 - 11/2002
2	Autoimmune Diseases (Autoimmune Disease) 05/2016 - 12/2007
2	Thrombocytopenia (Thrombopenia) 07/2014 - 06/2009
2	Pruritus (Itching) 07/2014 - 02/2013
2	Inflammation (Inflammations) 01/2013 - 02/2010
2	Nausea 07/2012 - 06/2011
2	Hepatitis 07/2012 - 01/2010
2	Nevus (Nevi) 07/2012 - 01/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2008 - 07/2008
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Infections 01/2022
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

22	IpilimumabIBA 04/2022 - 10/2010
17	dabrafenibIBA 01/2020 - 07/2012
16	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2014
16	VemurafenibIBA 11/2021 - 06/2011
14	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 02/2003
13	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2016
13	trametinibIBA 01/2020 - 11/2014
13	Interferon-alpha (Interferon Alfa)IBA 02/2013 - 08/2003
12	InterferonsIBA 05/2018 - 07/2008
11	Biomarkers (Surrogate Marker)IBA 04/2022 - 03/2012
11	Pharmaceutical PreparationsIBA 01/2022 - 01/2005
11	HhAntag691IBA 01/2019 - 06/2012
9	pembrolizumabIBA 04/2022 - 01/2015
9	Interferon alpha-2 (Roferon-A)FDA Link 08/2021 - 08/2003
9	Phosphotransferases (Kinase)IBA 01/2020 - 07/2008
8	Monoclonal AntibodiesIBA 01/2020 - 02/2010
7	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2020 - 12/2007
7	AntibodiesIBA 01/2018 - 10/2010
6	Interleukin-2 (IL2)IBA 09/2019 - 08/2003
5	cemiplimabIBA 01/2021 - 01/2018
5	Biological ProductsIBA 01/2018 - 12/2008
5	Sorafenib (BAY 43-9006)FDA Link 09/2013 - 04/2007
5	tremelimumabIBA 02/2013 - 02/2010
4	Mitogen-Activated Protein KinasesIBA 03/2019 - 01/2014
4	Proto-Oncogene Proteins B-rafIBA 01/2017 - 06/2011
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2014 - 10/2003
3	NivolumabIBA 04/2022 - 01/2015
3	cobimetinibIBA 01/2020 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 09/2019 - 01/2014
3	Programmed Cell Death 1 ReceptorIBA 07/2018 - 01/2015
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2010 - 10/2005
2	Dihydrotachysterol (AT 10)IBA 11/2022 - 01/2020
2	PlacebosIBA 01/2020 - 01/2019
2	sonidegibIBA 01/2020 - 10/2016
2	binimetinibIBA 03/2019 - 03/2013
2	AcidsIBA 01/2019 - 02/2009
2	talimogene laherparepvecIBA 01/2019 - 10/2018
2	LigandsIBA 07/2018 - 01/2015
2	TropomyosinIBA 07/2018 - 11/2017
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2017 - 03/2013
2	S100 Calcium Binding Protein beta SubunitIBA 01/2016 - 02/2009
2	Histone Deacetylase InhibitorsIBA 06/2015 - 08/2008
2	elesclomolIBA 02/2015 - 03/2013
2	Temozolomide (Temodar)FDA LinkGeneric 02/2013 - 06/2009
2	peginterferon alfa-2b (Pegintron)FDA Link 01/2013 - 07/2008
2	Cisplatin (Platino)FDA LinkGeneric 12/2011 - 02/2003
2	Vindesine (Vindesin)IBA 12/2011 - 10/2008
2	Carboplatin (JM8)FDA LinkGeneric 06/2009 - 10/2003
2	liposomal doxorubicin (Doxil)FDA Link 04/2008 - 09/2003
2	Imiquimod (Aldara)FDA LinkGeneric 01/2005 - 11/2002
1	relatlimabIBA 04/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021

Therapy/Procedure

78	Therapeutics 04/2022 - 02/2003
18	Drug Therapy (Chemotherapy) 04/2022 - 02/2003
13	Immunotherapy 04/2022 - 12/2008
6	Radiotherapy 01/2020 - 02/2008
3	Aftercare (After-Treatment) 01/2016 - 10/2009
3	Palliative Care (Palliative Therapy) 12/2015 - 01/2007
3	Duration of Therapy 01/2014 - 07/2008
3	Lymph Node Excision (Lymph Node Dissection) 08/2013 - 02/2008
3	Photochemotherapy (Photodynamic Therapy) 01/2010 - 10/2005
2	Injections 10/2018 - 02/2003
2	General Anesthesia 09/2006 - 01/2002
1	Organ Transplantation 01/2022